Skip to main content
Clinical Trials/NCT03585582
NCT03585582
Recruiting
Not Applicable

Pediatric Acute Respiratory Distress Syndrome: Determining Post-discharge Outcomes, the Effect of Early Diagnosis, and Identifying Inflammatory Signatures to Better Understand Disease Mechanism

St. Justine's Hospital1 site in 1 country77 target enrollmentOctober 31, 2018

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Pediatric Acute Respiratory Distress Syndrome
Sponsor
St. Justine's Hospital
Enrollment
77
Locations
1
Primary Endpoint
Prevalence of respiratory symptoms
Status
Recruiting
Last Updated
3 years ago

Overview

Brief Summary

In this study, the investigators aim to better characterize the outcomes of pediatric acute respiratory distress syndrome (PARDS) survivors, to examine whether subgroups of children with PARDS can be identified, and to determine whether an earlier diagnosis of PARDS using a computerized decision support system will improve the care of these children.

Detailed Description

Pediatric acute respiratory distress syndrome (PARDS), a heterogeneous clinical syndrome characterized by acute lung injury and hypoxemia, affects up to 10% of pediatric intensive care unit (ICU) patients and has a mortality rate of 18-27%. Because children who survived PARDS are still developing, long-term morbidities are highly relevant, although data on the outcomes of PARDS survivors is lacking. Previous studies were limited by their sample size, were outdated in PARDS management strategies, and used the adult ARDS diagnostic criteria. Some studies focused on pulmonary function but not on other patient-oriented outcomes such as respiratory symptoms, mental health issues, quality of life, and health care resource use, all of which have been identified as prevalent issues in adult ARDS survivors. Recently, adult studies have identified 2 distinct ARDS subphenotypes with differential responses to treatment using clinical and limited biological data, providing insight on the pathophysiology of ARDS. Whether these phenotypes are present in PARDS is unknown. Furthermore, integrating newer technologies such as transcriptomics in the identification of subphenotypes may improve our understanding of disease mechanisms. Finally, delays in ARDS diagnosis are common and compliance with current ARDS ventilation management guidelines is poor, ranging from 20-39% even in patients selected for clinical trials. Thus, novel methods such as decision support systems may play a role in the diagnosis and management of PARDS patients, although this remains to be evaluated.

Registry
clinicaltrials.gov
Start Date
October 31, 2018
End Date
August 1, 2023
Last Updated
3 years ago
Study Type
Observational
Sex
All

Investigators

Sponsor
St. Justine's Hospital
Responsible Party
Principal Investigator
Principal Investigator

Sze Man Tse

Pediatric Respirologist, Assistant Clinical Professor

St. Justine's Hospital

Eligibility Criteria

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • Not provided

Outcomes

Primary Outcomes

Prevalence of respiratory symptoms

Time Frame: At 1 year following the discharge

Prevalence of respiratory symptoms (cough, exercise intolerance, wheezing, etc.)

Secondary Outcomes

  • Pulmonary function - Forced expiratory volume in 1 second(At 1 year following the discharge)
  • Pulmonary function - lung volumes(At 1 year following the discharge)
  • Cardiopulmonary exercise testing - CO2 output(At 1 year following the discharge)
  • Cardiopulmonary exercise testing - respiratory exchange ratio(At 1 year following the discharge)
  • Cardiopulmonary exercise testing - anaerobic threshold(At 1 year following the discharge)
  • Pulmonary function - diffusion capacity(At 1 year following the discharge)
  • Pulmonary function - maximal inspiratory and expiratory pressures(At 1 year following the discharge)
  • Pulmonary function - resistance at 5Hz(At 1 year following the discharge)
  • Cardiopulmonary exercise testing - VO2max(At 1 year following the discharge)
  • non-respiratory PELOD-2 score(At 7 days)
  • Pulmonary function - FEV1/FVC(At 1 year following the discharge)
  • Pulmonary function - Forced vital capacity (FVC)(At 1 year following the discharge)
  • Health-related quality of life - Infant Toddler Quality of Life Questionnaire(At 1 year following the discharge)
  • Health-related quality of life - Pediatric Quality of Life Inventory(At 1 year following the discharge)
  • Mental health - Child Behavior Checklist(At 1 year following the discharge)
  • Post-traumatic stress syndrome - Children's Impact of Event Scales(At 1 year following the discharge)
  • Post-traumatic stress syndrome - parents PTSD Checklist(At 1 year following the discharge)
  • Health resources use(At 1 year following the discharge)

Study Sites (1)

Loading locations...

Similar Trials